SARS-CoV-2 Spike receptor binding domain, RBD (336-347) – Lys(Biotin-LC)

Product Name: SARS-CoV-2 Spike receptor binding domain, RBD (336-347) - Lys(Biotin-LC)

Sequence One Letter Code: CPFGEVFNATRF-K(Biotin-LC)-NH2

Sequence Three Letter Code: H-Cys-Pro-Phe-Gly-Glu-Val-Phe-Asn-Ala-Thr-Arg-Phe-Lys(Biotin-LC)-NH2

Molecular Weight: 1854.3

Purity: ≥ 95% 

Storage Conditions: - 20 °C

Source / Species: SARS-CoV-2

Conjugation: Conjugated

Conjugation Type: Biotins

Code Nacres: NA.26

Application: SARS-CoV-2 Spike RBD (336–347)-Biotin-LC is a synthetic peptide representing residues 336–347 of the SARS-CoV-2 spike receptor-binding domain. Derived from RefSeq YP_009724390.1, this peptide is labeled with C-terminal Biotin-LC to support affinity capture, immobilization, and detection in assay systems. The RBD plays a central role in ACE2-mediated viral entry and is a primary antigenic region of the spike protein. This biotin-tagged spike peptide is useful for receptor interaction studies, antibody profiling, vaccine epitope analysis, immune recognition research, and diagnostic assay development requiring immobilized RBD-derived fragments.